US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Innate Pharma SA

2.10

+0.11966.04%

Post-market: 2.05-0.0496-2.36%16:00 EDT

Volume:35.15K

Turnover:73.64K

Market Cap:175.97M

PE:-3.32

High:2.14

Open:2.03

Low:2.02

Close:1.98

Loading ...

Overview Company News Filings

3 Promising Penny Stocks With Market Caps Under US$500M

Simply Wall St.

Sector Update: Health Care Stocks Mixed Premarket Monday

MT Newswires Live

Innate Pharma doses first patient in IPH4502 study

Innate Pharma Doses First Patient in Phase 1 Trial of Cancer Drug Candidate

MT Newswires Live

Innate Pharma Announces First Patient Dosed in Phase 1 Study of Its Nectin-4 Targeting Antibody Drug Conjugate IPH4502 in Selected Advanced Solid Tumors

Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York

Citi Keeps Their Buy Rating on Innate Pharma (IPHA)

Innate Pharma Price Target Maintained With a $11.50/Share by HC Wainwright & Co.

Number of Shares and Voting Rights of Innate Pharma as of December 31, 2024

Innate Pharma to Focus on NK Cell Therapies, ADC Development to Accelerate Growth

MT Newswires Live

Innate Pharma Announces Transformative Strategy to Accelerate Growth

Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

3 Promising Penny Stocks With Market Caps Under US$300M

Simply Wall St.

Innate Pharma Price Target Maintained With a $11.50/Share by HC Wainwright & Co.

Innate Pharma SA Reveals Promising Lacutamab Trial Results

Innate Pharma announces new data from TELLOMAK study

Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma

Sector Update: Health Care Stocks Edge Higher Premarket Friday

MT Newswires Live

Innate Pharma partners with IFLI to study IPH6501, to receive $3M upfront

Innate Pharma, Institute for Follicular Lymphoma Collaborate to Study IPH6501 in Follicular Lymphoma

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IPHA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IPHA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPHA\",,,,,undefined,":{"symbol":"IPHA","market":"US","secType":"STK","nameCN":"Innate Pharma SA","latestPrice":2.0996,"timestamp":1745870399999,"preClose":1.98,"halted":0,"volume":35151,"hourTrading":{"tag":"盘后","latestPrice":2.05,"preClose":2.0996,"latestTime":"16:00 EDT","volume":4,"amount":8.2,"timestamp":1745870402996},"delay":0,"floatShares":34421993,"shares":83811761,"eps":-0.631909,"marketStatus":"Post-Mkt","change":0.1196,"latestTime":"04-28 16:00:40 EDT","open":2.03,"high":2.14,"low":2.02,"amount":73637.724447,"amplitude":0.060606,"askPrice":2.1,"askSize":530,"bidPrice":2.02,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.631909,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745884800000},"marketStatusCode":4,"adr":0,"adrRate":1,"listingDate":1571284800000,"exchange":"NASDAQ","adjPreClose":1.98,"preHourTrading":{"tag":"盘前","latestPrice":2.06,"preClose":1.98,"latestTime":"09:29 EDT","volume":465,"amount":958.119945,"timestamp":1745846990084},"postHourTrading":{"tag":"盘后","latestPrice":2.05,"preClose":2.0996,"latestTime":"16:00 EDT","volume":4,"amount":8.2,"timestamp":1745870402996},"volumeRatio":1.516339},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPHA\",,,,,undefined,":{"symbol":"IPHA","floatShares":34421993,"roa":"-21.84%","roe":"-162.91%","lyrEps":-0.631909,"volumeRatio":1.516339,"shares":83811761,"dividePrice":0,"high":2.14,"amplitude":0.060606,"preClose":1.98,"low":2.02,"week52Low":1.29,"pbRate":"17.44","psRate":"7.66","week52High":3.5107,"institutionHeld":0,"latestPrice":2.0996,"committee":-0.996234,"eps":-0.631909,"divideRate":0,"volume":35151,"delay":0,"ttmEps":-0.631909,"open":2.03,"prevYearClose":1.84,"prevWeekClose":1.98,"prevMonthClose":1.78,"prevQuarterClose":1.78,"fiveDayClose":1.93,"twentyDayClose":1.98,"sixtyDayClose":1.79},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IPHA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2508680991","title":"3 Promising Penny Stocks With Market Caps Under US$500M","url":"https://stock-news.laohu8.com/highlight/detail?id=2508680991","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508680991?lang=en_us&edition=fundamental","pubTime":"2025-02-01 03:06","pubTimestamp":1738350360,"startTime":"0","endTime":"0","summary":"As global markets continue to march toward record highs, driven by optimism around tariffs and AI developments, investors are increasingly looking for opportunities in smaller-cap stocks. Penny stocks, while often associated with higher risk, can still offer significant potential when backed by strong financials and clear growth prospects. This article will explore three such penny stocks that stand out due to their balance sheet strength and promising potential for future gains.Overview: Innate Pharma S.A. is a biotechnology company focused on developing immunotherapies for cancer patients in France and internationally, with a market cap of 146.34 million.Overview: YesAsia Holdings Limited is an investment holding company involved in the procurement, sale, and trading of Asian fashion and lifestyle products, including beauty, cosmetics, accessories, and entertainment items, with a market cap of HK$1.42 billion.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-promising-penny-stocks-market-190600988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","IPHA"],"gpt_icon":0},{"id":"2506550370","title":"Sector Update: Health Care Stocks Mixed Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2506550370","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506550370?lang=en_us&edition=fundamental","pubTime":"2025-01-27 22:11","pubTimestamp":1737987112,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed premarket Monday, with The Health Care Select Sector SPDR Fund  up 0.4% and the iShares Biotechnology ETF  0.3% lower.Akero Therapeutics  shares were up over 110% after the company said a phase 2b study of its lead product candidate efruxifermin showed a \"statistically significant\" reversal of compensated cirrhosis caused by metabolic dysfunction-associated steatohepatitis, or MASH.Allakos  stock was down past 73% after the company said its phase 1 trial of AK006 in chronic spontaneous urticaria failed to demonstrate therapeutic efficacy and its development will be terminated immediately.Innate Pharma  shares were up over 7% after the company said it has dosed its first patient in a phase 1 study to investigate the safety and tolerability of IPH4502, an antibody-drug conjugate for the potential treatment of patients with advanced solid tumors known to express Nectin-4.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","AKRO","BK4139","BK4581","BK4505","IPHA","BK4588","XLV","ALLK","IBB"],"gpt_icon":0},{"id":"2506111327","title":"Innate Pharma doses first patient in IPH4502 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2506111327","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506111327?lang=en_us&edition=fundamental","pubTime":"2025-01-27 18:30","pubTimestamp":1737973836,"startTime":"0","endTime":"0","summary":"Innate Pharma (IPHA) announced the first patient was dosed in its Phase 1 study, investigating the safety and tolerability of IPH4502, an Antibody-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/innate-pharma-doses-first-patient-in-iph4502-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/innate-pharma-doses-first-patient-in-iph4502-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPHA","IPHYF","BK4139"],"gpt_icon":0},{"id":"2506298923","title":"Innate Pharma Doses First Patient in Phase 1 Trial of Cancer Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2506298923","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506298923?lang=en_us&edition=fundamental","pubTime":"2025-01-27 17:10","pubTimestamp":1737969023,"startTime":"0","endTime":"0","summary":"Innate Pharma SA  said Monday it has dosed its first patient in a phase 1 study to investigate the safety and tolerability of IPH4502, an antibody-drug conjugate for the potential treatment of patients with advanced solid tumors known to express Nectin-4.IPH4502 is designed to target Nectin-4, a cell adhesion molecule in several types of solid tumors, including urothelial carcinoma, breast cancer, non-small cell lung cancer, and gastrointestinal cancer, the company said.The study plans to enroll about 105 patients, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IPHYF","IPHA"],"gpt_icon":0},{"id":"2506462483","title":"Innate Pharma Announces First Patient Dosed in Phase 1 Study of Its Nectin-4 Targeting Antibody Drug Conjugate IPH4502 in Selected Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2506462483","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506462483?lang=en_us&edition=fundamental","pubTime":"2025-01-27 14:00","pubTimestamp":1737957600,"startTime":"0","endTime":"0","summary":"IPH4502 is a novel and differentiated topoisomerase I inhibitor ADC conjugated to exatecan targeting Nectin-4. IPH4502 is a novel and differentiated topoisomerase I inhibitor ADC designed to precisely target Nectin-4, a cell adhesion molecule that is overexpressed in several types of solid tumors, including urothelial carcinoma , breast cancer, non-small cell lung cancer or gastro-intestinal cancer. IPH4502 targets tumors with a wide range of Nectin-4 expression, supporting its development beyond UC. IPH4502 differentiated topoisomerase I inhibitor payload supports its potential in patients with tumors resistant to MMAE-ADC.The Phase 1, open-label, multi-center study, includes a Part 1 Dose Escalation and a Part 2 Dose Optimization, and will assess the safety, tolerability, and preliminary efficacy of IPH4502 as a single agent in advanced solid tumors known to express Nectin-4, including but not limited to urothelial carcinoma, non-small cell lung, breast, ovarian, gastric, esophageal,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innate-pharma-announces-first-patient-060000469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0031619046.USD","IPHA","IE00B7SZL793.SGD","BK4231","IE00B66KJ199.SGD","BK4157","IE00B19Z4B17.USD","AEIS","BK4080","BK4139","IPHYF","ADC"],"gpt_icon":0},{"id":"2505297041","title":"Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York","url":"https://stock-news.laohu8.com/highlight/detail?id=2505297041","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505297041?lang=en_us&edition=fundamental","pubTime":"2025-01-21 14:00","pubTimestamp":1737439200,"startTime":"0","endTime":"0","summary":"Innate Pharma to highlight IPH4502, its lead Nectin-4 Antibody Drug Conjugate  program at clinical stage. Innate Pharma SA   will host an event for institutional investors and analysts dedicated to its Antibody-Drug Conjugate  strategy, and particularly Nectin-4, the target of its lead antibody-drug candidate program, IPH4502. The event will be held in New York in a hybrid format on Wednesday, February 5, 2025, from 10:00 a.m. to 12:00 p.m. EDT.\"As we just updated our strategy with a focus on our ANKET platform and ADC programs, this meeting will be an opportunity to share the latest scientific and clinical advancements related to Nectin-4 and its potential in cancer treatment,\" said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. In September 2024, the U.S Food and Drug Administration  has cleared its investigational new drug  application to initiate a Phase 1 clinical study of IPH4502.Headquartered in Marseille, France with a US office in Rockville, MD, Innate Pharma is","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innate-pharma-announces-nectin-4-060000163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ADC","IPHA","IPHYF","BK4080","BK4231"],"gpt_icon":0},{"id":"2504068471","title":"Citi Keeps Their Buy Rating on Innate Pharma (IPHA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2504068471","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504068471?lang=en_us&edition=fundamental","pubTime":"2025-01-20 17:26","pubTimestamp":1737365164,"startTime":"0","endTime":"0","summary":"In a report released on January 17, Sean Lee from Citi reiterated a Buy rating on Innate Pharma (IPHA – Research Report), with a price target of $1...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-keeps-their-buy-rating-on-innate-pharma-ipha?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-keeps-their-buy-rating-on-innate-pharma-ipha?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPHA"],"gpt_icon":0},{"id":"2504150945","title":"Innate Pharma Price Target Maintained With a $11.50/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2504150945","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504150945?lang=en_us&edition=fundamental","pubTime":"2025-01-17 21:03","pubTimestamp":1737118980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IPHA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 17, 2025 08:03 ET (13:03 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPHYF","IPHA"],"gpt_icon":0},{"id":"2503956444","title":"Number of Shares and Voting Rights of Innate Pharma as of December 31, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2503956444","media":"Business Wire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503956444?lang=en_us&edition=fundamental","pubTime":"2025-01-16 14:00","pubTimestamp":1737007200,"startTime":"0","endTime":"0","summary":"Pursuant to the article L. 233-8 II of the French \"Code de Commerce\" and the article 223-16 of the French stock-market authorities  General Regulation, Innate Pharma SA   releases its total number of shares outstanding as well as its voting rights as of December 31, 2024:.  The total number of theoretical voting rights  is used as the basis for calculating the crossing of shareholding thresholds. In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all shares to which voting rights are attached, including shares whose voting rights have been suspended. The total number of theoretical voting rights includes voting rights attached to AGAP 2016, i.e. 130 voting rights for the AGAP 2016-1 and 111 voting rights for the AGAP 2016-2. No voting rights attached to AGAP 2017. The total number of exercisable voting rights  is calculated without taking into account the shares held in treasury by the Company, with suspended voting rights. It is ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/number-shares-voting-rights-innate-060000066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IPHYF","ADC","BK4231","IPHA","BK4080","BK4139"],"gpt_icon":0},{"id":"2502378788","title":"Innate Pharma to Focus on NK Cell Therapies, ADC Development to Accelerate Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2502378788","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502378788?lang=en_us&edition=fundamental","pubTime":"2025-01-10 17:39","pubTimestamp":1736501995,"startTime":"0","endTime":"0","summary":"Innate Pharma (IPHA) said Friday it is prioritizing its antibody-based NK Cell Engager platform to target hematologic cancers, solid tumors, and autoimmune diseases.The company said it is currently te","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADC","IPHYF","BK4139","LU2417539215.USD","LU1829250122.USD","IPHA","BK4007","LU0109394709.USD","BK4080","BK4585","LU2462157665.USD","LU2236285917.USD","LU0889565916.HKD","BK4568","LU2456880835.USD","LU0320765992.SGD","AAQC","AZN","BK4231","BK4588"],"gpt_icon":0},{"id":"2502884619","title":"Innate Pharma Announces Transformative Strategy to Accelerate Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2502884619","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502884619?lang=en_us&edition=fundamental","pubTime":"2025-01-10 14:00","pubTimestamp":1736488800,"startTime":"0","endTime":"0","summary":"Strategy anchored on early clinical development of proprietary assets with single-agent potential:. Drive innovation with first-in-class ANKET NK-cell engager Platform. Innate Pharma SA   today announced its updated strategy for company growth. This comprehensive plan is anchored in three key pillars designed to drive sustainable growth, foster innovation, and deliver transformative therapies to patients worldwide.\"Our updated strategy underscores Innate Pharma’s unwavering dedication to innovation, collaboration, and delivering transformative therapies for patients worldwide,\" said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. \"With a focus on our ANKET platform and ADC programs, we are poised to redefine the landscape of immunotherapy, addressing unmet needs in oncology and autoimmune diseases. This roadmap reflects our steadfast commitment to advancing science, strengthening partnerships, and maximizing value for patients and shareholders alike as we look toward a br","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innate-pharma-announces-transformative-strategy-060000976.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","IPHA","AAQC","BK4231","IPHYF","BK4139","ADC"],"gpt_icon":0},{"id":"2492493694","title":"Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2492493694","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492493694?lang=en_us&edition=fundamental","pubTime":"2024-12-20 14:00","pubTimestamp":1734674400,"startTime":"0","endTime":"0","summary":"Innate Pharma SA   today announced that its management will present and host 1x1 meetings at the 43rd Annual J.P. Morgan Healthcare Conference being held on January 13-16, 2025 in San Francisco, CA.Jonathan Dickinson, Chief Executive Officer of Innate Pharma, will represent the Company in a session scheduled Tuesday, January 14, 2025 from 11:15 - 11:55 am PST.Other Executive Board members participating in the event will be:. A live video webcast of the presentation will be accessible under the \"Events\" tab on the Investors section of the Company’s website at www.innate-pharma.com and will be available for replay following the event.This press release contains certain forward-looking statements, including those within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. The use of certain words, including \"anticipate,\" \"believe,\" \"can,\" \"could,\" \"estimate,\" \"expect,\" \"may,\" \"might,\" \"potential,\" \"expect\" \"should,\" \"will,\" or the nega","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xscUo4qnoO9SNvb3DDE4AA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/63390f0d711d97e48569a217f06c9310","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xscUo4qnoO9SNvb3DDE4AA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/63390f0d711d97e48569a217f06c9310"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innate-pharma-participate-43rd-annual-060000383.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IPHA","IE00BZ1G4Q59.USD","LU0225283273.USD","LU2347655156.SGD","LU2357305700.SGD","LU1162221912.USD","LU2271345857.HKD","LU2023251221.USD","BK4581","LU2028103732.USD","HCSG","BK4127","LU1548497426.USD","LU2089284900.SGD","LU1732799900.SGD","ADC","LU2111349929.HKD","LU1989772923.USD","BK4585","LU0267386448.USD","BK4588","BK4139","LU0912757837.SGD","LU0971096721.USD","IE00BKVL7J92.USD","BK4534","BK4080","LU1668664300.SGD","BK4231","LU1720051017.SGD","LU0158827781.USD","BK4516","LU1989772840.SGD","LU0106261372.USD","LU1363072403.SGD","LU1720051108.HKD","IPHYF","LU0106831901.USD","BK4504","LU0795875169.SGD","LU2089283258.USD","LU0098860793.USD","LU0158827948.USD","LU0795875086.SGD","LU0006306889.USD","LU1732800096.USD","BK4137","LU0314104364.USD","LU0320765646.SGD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2490847912","title":"3 Promising Penny Stocks With Market Caps Under US$300M","url":"https://stock-news.laohu8.com/highlight/detail?id=2490847912","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490847912?lang=en_us&edition=fundamental","pubTime":"2024-12-12 10:07","pubTimestamp":1733969242,"startTime":"0","endTime":"0","summary":"As global markets experience a mixed performance, with major U.S. indices reaching record highs while others face declines, investors continue to navigate through a complex economic landscape. Amidst this backdrop, penny stocks remain an intriguing option for those looking to explore smaller or less-established companies that may offer value and growth potential. Despite being considered an outdated term by some, penny stocks highlight opportunities in firms with strong financials and the potential for significant returns. In this article, we spotlight three such stocks that stand out due to their robust balance sheets and promising prospects.Overview: Innate Pharma S.A. is a biotechnology company focused on developing immunotherapies for cancer patients both in France and internationally, with a market cap of 129.52 million.Overview: 3D Medicines Inc. is a biopharmaceutical company that focuses on researching, developing, and commercializing oncology products for cancer treatment in M","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/g2_mg575ViI8K4GruDHCHQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/67ac92a32c5f9073ba3559a3e119b22a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/g2_mg575ViI8K4GruDHCHQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/67ac92a32c5f9073ba3559a3e119b22a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-promising-penny-stocks-market-020722794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IPHA","BK4139"],"gpt_icon":0},{"id":"2490572399","title":"Innate Pharma Price Target Maintained With a $11.50/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2490572399","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490572399?lang=en_us&edition=fundamental","pubTime":"2024-12-09 19:39","pubTimestamp":1733744340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IPHA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 09, 2024 06:39 ET (11:39 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPHA","IPHYF"],"gpt_icon":0},{"id":"2490695723","title":"Innate Pharma SA Reveals Promising Lacutamab Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2490695723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490695723?lang=en_us&edition=fundamental","pubTime":"2024-12-09 19:30","pubTimestamp":1733743806,"startTime":"0","endTime":"0","summary":"Innate Pharma SA (FR:IPH) has released an update. Innate Pharma SA has unveiled promising data from its TELLOMAK Phase 2 study, highlighting the po...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/innate-pharma-sa-reveals-promising-lacutamab-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/innate-pharma-sa-reveals-promising-lacutamab-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPHA","BK4139"],"gpt_icon":0},{"id":"2490742464","title":"Innate Pharma announces new data from TELLOMAK study","url":"https://stock-news.laohu8.com/highlight/detail?id=2490742464","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490742464?lang=en_us&edition=fundamental","pubTime":"2024-12-09 18:35","pubTimestamp":1733740514,"startTime":"0","endTime":"0","summary":"Innate Pharma (IPHA) announced new data highlighting the quality-of-life improvements observed in patients with cutaneous T-cell lymphoma, or CTCL,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/innate-pharma-announces-new-data-from-tellomak-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/innate-pharma-announces-new-data-from-tellomak-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IPHA","IPHYF"],"gpt_icon":0},{"id":"2490713101","title":"Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2490713101","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490713101?lang=en_us&edition=fundamental","pubTime":"2024-12-09 14:00","pubTimestamp":1733724000,"startTime":"0","endTime":"0","summary":"Findings reveal promising early signs that lacutamab may help alleviate some of the most distressing symptoms of cutaneous T cell lymphomas. Innate Pharma SA   today announced new data highlighting the quality-of-life improvements observed in patients with cutaneous T-cell lymphoma  treated with lacutamab in the TELLOMAK Phase 2 clinical study. These data were presented at the 66th American Society of Hematology  Annual Meeting in San Diego, California.The TELLOMAK study addresses a critical unmet need for patients with advanced-stage CTCL, particularly Sézary syndrome  and mycosis fungoides , who often experience debilitating symptoms such as severe itching and recurrent skin infections that profoundly impact their physical and social well-being.Patient Profile: Median age of 69, advanced disease , and a median of five prior systemic therapies, high score of pruritus  and severe Skindex-29 score  at","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/S3d2z6.8Hd_WflLKKLjigw--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/646921f25dc14927fb658297457f5944","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/S3d2z6.8Hd_WflLKKLjigw--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/646921f25dc14927fb658297457f5944"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innate-pharma-presents-lacutamab-improved-060000716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","LU2463526074.USD","BK4139","BK4109","MF","ADC","ASH","BK4526","BK4563","BK4113","IPHA","IPHYF","BK4080","BK4231"],"gpt_icon":0},{"id":"2489252546","title":"Sector Update: Health Care Stocks Edge Higher Premarket Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2489252546","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489252546?lang=en_us&edition=fundamental","pubTime":"2024-12-06 22:08","pubTimestamp":1733494086,"startTime":"0","endTime":"0","summary":"Health care stocks were edging higher premarket Friday as the iShares Biotechnology ETF  advanced by 0.4% and the Health Care Select Sector SPDR Fund  was up 0.2% recently.Veeva Systems  shares rose by over 7% after the company reported an increase in fiscal Q3 earnings and sales while lifting its guidance for fiscal 2025.Innate Pharma  shares were up more than 8% after the company and the Institute for Follicular Lymphoma said they have agreed to study the potential of the company's IPH6501 experimental therapy in follicular lymphoma, a type of blood cancer.Cooper  shares fell past 4% after the company issued fiscal 2025 guidance that fell short of market expectations.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1989764664.SGD","BK7016","VEEV","BK4581","LU2272731600.USD","LU0058720904.USD","BK4198","LU0266013472.USD","COO.AU","IBB","COO","BK4528","GB00BDT5M118.USD","LU2272731782.SGD","XLV","BK4585","LU0289739699.SGD","BK4534","LU1992135399.USD","LU1992135472.HKD","LU2211815571.USD","BK4139","BK4588","IPHA","BK4504","LU1989764748.USD","BK4167"],"gpt_icon":0},{"id":"2489517402","title":"Innate Pharma partners with IFLI to study IPH6501, to receive $3M upfront","url":"https://stock-news.laohu8.com/highlight/detail?id=2489517402","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489517402?lang=en_us&edition=fundamental","pubTime":"2024-12-06 18:15","pubTimestamp":1733480118,"startTime":"0","endTime":"0","summary":"Innate Pharma (IPHA) with the Institute for Follicular Lymphoma, or IFLI, announced that they have entered into an agreement to clinically study th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/innate-pharma-partners-with-ifli-to-study-iph6501-to-receive-3m-upfront?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/innate-pharma-partners-with-ifli-to-study-iph6501-to-receive-3m-upfront?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","BK4534","BK4139","LU1093756168.USD","BK4512","LU1093756325.SGD","MMM","BK4588","BK4206","IPHA","IPHYF","BK4585"],"gpt_icon":0},{"id":"2489067404","title":"Innate Pharma, Institute for Follicular Lymphoma Collaborate to Study IPH6501 in Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2489067404","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489067404?lang=en_us&edition=fundamental","pubTime":"2024-12-06 17:27","pubTimestamp":1733477233,"startTime":"0","endTime":"0","summary":"Innate Pharma (IPHA) and the Institute for Follicular Lymphoma said Friday they have agreed to study the potential of the company's IPH6501 experimental therapy in follicular lymphoma, a type of blood","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IPHYF","IPHA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPHA\",params:#limit:5,,,undefined,":[{"date":"2025-03-27","symbol":"IPHA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":null,"defaultRemindTime":1743062400000,"name":null,"time":"Pre-Market","dateTimestamp":1743048000000,"actualEps":null},{"market":"US","date":"2024-11-13","symbol":"IPHA","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":null},{"date":"2024-09-12","symbol":"IPHA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/06","expectedEps":null,"defaultRemindTime":1726128000000,"name":null,"time":"Pre-Market","dateTimestamp":1726113600000,"actualEps":null},{"date":"2024-05-14","symbol":"IPHA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/03","expectedEps":null,"defaultRemindTime":1715673600000,"name":null,"time":"Pre-Market","dateTimestamp":1715659200000,"actualEps":null},{"date":"2024-03-21","symbol":"IPHA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2023/12","expectedEps":null,"defaultRemindTime":1711008000000,"name":null,"time":"Pre-Market","dateTimestamp":1710993600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPHA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IPHA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.25,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":4,"updateTime":1630641600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IPHA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IPHA","date":"2025-04-25","current":-2.978332,"percent":0.941708,"low":-29.261169,"twenty":-10.145916,"median":-4.873349,"eighty":-3.632766,"high":-2.631307,"avg":-7.923841,"sd":6.747562,"marketCap":167299960.26},"quantilePoints":[{"date":"2020-05-01","current":-24.508598,"twenty":-89.948317,"median":-9.990555,"eighty":15.929947,"marketCap":559707364.14},{"date":"2020-05-08","current":-26.218501,"twenty":-89.948317,"median":-10.05424,"eighty":15.854923,"marketCap":590762893.74},{"date":"2020-05-15","current":-22.969686,"twenty":-89.777313,"median":-10.109964,"eighty":15.842419,"marketCap":516047316.02},{"date":"2020-05-22","current":-21.240785,"twenty":-89.614307,"median":-10.169669,"eighty":15.754892,"marketCap":480324031.59},{"date":"2020-05-29","current":-21.563767,"twenty":-89.607908,"median":-10.18161,"eighty":15.734886,"marketCap":497656737.08},{"date":"2020-06-05","current":-21.392777,"twenty":-89.546835,"median":-10.221413,"eighty":15.699875,"marketCap":502594668.4},{"date":"2020-06-12","current":-21.012798,"twenty":-89.531967,"median":-10.249275,"eighty":15.322051,"marketCap":490172693.56},{"date":"2020-06-19","current":-21.772755,"twenty":-89.317833,"median":-10.348782,"eighty":15.079631,"marketCap":505967331.24},{"date":"2020-06-26","current":-21.620764,"twenty":-89.156376,"median":-10.380625,"eighty":15.022165,"marketCap":503111119.83},{"date":"2020-07-02","current":-20.651819,"twenty":-88.984469,"median":-10.428388,"eighty":15.015934,"marketCap":481968644.18},{"date":"2020-07-10","current":-20.575823,"twenty":-88.840629,"median":-10.484113,"eighty":15.008991,"marketCap":483237374.14},{"date":"2020-07-17","current":-21.012798,"twenty":-88.77443,"median":-10.527896,"eighty":14.986534,"marketCap":498519634.29},{"date":"2020-07-24","current":-20.822809,"twenty":-88.591682,"median":-10.595561,"eighty":14.932491,"marketCap":502745632.71},{"date":"2020-07-31","current":-19.644877,"twenty":-88.48528,"median":-10.678955,"eighty":14.8146,"marketCap":482441727.2},{"date":"2020-08-07","current":-19.92986,"twenty":-88.196504,"median":-10.707009,"eighty":14.733293,"marketCap":487652013.2},{"date":"2020-08-14","current":-19.70343,"twenty":-88.003987,"median":-10.766723,"eighty":14.706851,"marketCap":483936933.27},{"date":"2020-08-21","current":-19.912636,"twenty":-88.003987,"median":-10.818475,"eighty":14.687209,"marketCap":486943585.82},{"date":"2020-08-28","current":-20.121842,"twenty":-87.954603,"median":-11.049333,"eighty":14.654288,"marketCap":496858954.44},{"date":"2020-09-04","current":-19.646373,"twenty":-87.681207,"median":-11.081175,"eighty":14.632781,"marketCap":481055750.18},{"date":"2020-09-11","current":-5.788616,"twenty":-87.295446,"median":-11.049333,"eighty":14.629622,"marketCap":303772148.44},{"date":"2020-09-18","current":-5.770805,"twenty":-86.796247,"median":-10.897755,"eighty":14.604535,"marketCap":303520097.28},{"date":"2020-09-25","current":-5.471578,"twenty":-86.554699,"median":-10.794593,"eighty":14.558443,"marketCap":281830443.82},{"date":"2020-10-02","current":-5.717371,"twenty":-86.264841,"median":-10.71099,"eighty":14.544151,"marketCap":296905503.1},{"date":"2020-10-09","current":-6.052221,"twenty":-85.603915,"median":-10.699049,"eighty":14.537014,"marketCap":317042533.38},{"date":"2020-10-16","current":-5.966776,"twenty":-84.942648,"median":-10.611482,"eighty":14.52451,"marketCap":309893503.98},{"date":"2020-10-23","current":-6.038021,"twenty":-84.362945,"median":-10.531876,"eighty":14.492,"marketCap":316860325.52},{"date":"2020-10-30","current":-6.059395,"twenty":-83.895962,"median":-10.492074,"eighty":14.441927,"marketCap":313053438.99},{"date":"2020-11-06","current":-6.233945,"twenty":-67.929429,"median":-10.428388,"eighty":14.41564,"marketCap":328541966.24},{"date":"2020-11-13","current":-7.18863,"twenty":-44.597456,"median":-10.380625,"eighty":14.39447,"marketCap":376884480.84},{"date":"2020-11-20","current":-7.498546,"twenty":-44.299936,"median":-10.348782,"eighty":14.379465,"marketCap":394251695.92},{"date":"2020-11-27","current":-8.246619,"twenty":-44.086332,"median":-10.253255,"eighty":14.376964,"marketCap":437108285.51},{"date":"2020-12-04","current":-8.064944,"twenty":-44.025302,"median":-10.229374,"eighty":14.366961,"marketCap":433911617.72},{"date":"2020-12-11","current":-6.212572,"twenty":-43.849842,"median":-10.18957,"eighty":14.351646,"marketCap":333602166.91},{"date":"2020-12-18","current":-6.358624,"twenty":-43.636238,"median":-10.169669,"eighty":14.290388,"marketCap":344743661.49},{"date":"2020-12-24","current":-6.283817,"twenty":-43.636238,"median":-10.133846,"eighty":14.290388,"marketCap":339483863.03},{"date":"2020-12-31","current":-6.166263,"twenty":-43.422634,"median":-10.062201,"eighty":14.281625,"marketCap":334396231.19},{"date":"2021-01-08","current":-6.921461,"twenty":-43.308203,"median":-10.030358,"eighty":14.262165,"marketCap":375764278.72},{"date":"2021-01-15","current":-6.828842,"twenty":-43.231916,"median":-9.058882,"eighty":14.25511,"marketCap":366029559.91},{"date":"2021-01-22","current":-6.565235,"twenty":-43.148,"median":-8.145095,"eighty":14.241034,"marketCap":354298925.14},{"date":"2021-01-29","current":-6.287379,"twenty":-42.964911,"median":-8.075631,"eighty":14.224204,"marketCap":338356862.1},{"date":"2021-02-05","current":-6.750472,"twenty":-42.85048,"median":-8.031147,"eighty":14.195216,"marketCap":360000828.82},{"date":"2021-02-12","current":-6.786095,"twenty":-42.835223,"median":-7.897518,"eighty":14.149393,"marketCap":364619978.18},{"date":"2021-02-19","current":-6.675665,"twenty":-42.804708,"median":-7.83696,"eighty":14.114383,"marketCap":359078203.11},{"date":"2021-02-26","current":-6.626502,"twenty":-42.743678,"median":-7.76546,"eighty":14.086874,"marketCap":355441903.21},{"date":"2021-03-05","current":-6.580188,"twenty":-42.720792,"median":-7.753304,"eighty":14.079372,"marketCap":347533336.91},{"date":"2021-03-12","current":-6.993454,"twenty":-42.644505,"median":-7.720872,"eighty":14.079372,"marketCap":370286388.39},{"date":"2021-03-19","current":-4.591347,"twenty":-42.514817,"median":-7.693801,"eighty":14.07437,"marketCap":349646194.95},{"date":"2021-03-26","current":-4.6185,"twenty":-42.461416,"median":-7.637272,"eighty":14.062368,"marketCap":348519989.39},{"date":"2021-04-01","current":-4.611095,"twenty":-42.408015,"median":-7.58967,"eighty":14.047865,"marketCap":347142336.75},{"date":"2021-04-09","current":-4.608626,"twenty":-42.369871,"median":-7.562893,"eighty":14.014398,"marketCap":350419881.16},{"date":"2021-04-16","current":-4.564194,"twenty":-42.324099,"median":-7.554462,"eighty":14.00458,"marketCap":349826746.53},{"date":"2021-04-23","current":-4.310296,"twenty":-42.25544,"median":-7.539092,"eighty":13.998456,"marketCap":332637807.26},{"date":"2021-04-30","current":-4.394231,"twenty":-42.163896,"median":-7.51529,"eighty":13.967834,"marketCap":338217835.92},{"date":"2021-05-07","current":-4.068367,"twenty":-41.912148,"median":-7.497439,"eighty":13.940534,"marketCap":316371394.02},{"date":"2021-05-14","current":-4.060961,"twenty":-41.874005,"median":-7.488514,"eighty":13.925052,"marketCap":315373852.41},{"date":"2021-05-21","current":-4.021462,"twenty":-41.835861,"median":-7.473638,"eighty":13.894729,"marketCap":313600526.51},{"date":"2021-05-28","current":-3.791938,"twenty":-41.797718,"median":-7.452812,"eighty":13.831795,"marketCap":295701864.72},{"date":"2021-06-04","current":-3.715408,"twenty":-41.767203,"median":-7.408836,"eighty":13.791783,"marketCap":289240399.08},{"date":"2021-06-11","current":-4.011653,"twenty":-41.423911,"median":-7.390333,"eighty":13.758692,"marketCap":310489459.3},{"date":"2021-06-18","current":-3.751395,"twenty":-41.30948,"median":-7.217773,"eighty":13.7221,"marketCap":284563408.42},{"date":"2021-06-25","current":-3.615564,"twenty":-40.928045,"median":-7.186203,"eighty":13.707765,"marketCap":276290754.81},{"date":"2021-07-02","current":-3.662487,"twenty":-40.241461,"median":-7.156953,"eighty":13.679248,"marketCap":277523199.91},{"date":"2021-07-09","current":-3.477264,"twenty":-40.180431,"median":-7.108859,"eighty":13.672281,"marketCap":263956869.14},{"date":"2021-07-16","current":-3.358909,"twenty":-40.104143,"median":-7.081762,"eighty":13.637493,"marketCap":253768403.59},{"date":"2021-07-23","current":-3.373728,"twenty":-39.844768,"median":-7.023772,"eighty":13.622291,"marketCap":253928504.88},{"date":"2021-07-30","current":-3.492278,"twenty":-38.807263,"median":-6.979759,"eighty":13.600437,"marketCap":265065135.23},{"date":"2021-08-06","current":-3.541674,"twenty":-38.41057,"median":-6.957564,"eighty":13.595407,"marketCap":266569162.45},{"date":"2021-08-13","current":-3.503079,"twenty":-38.280881,"median":-6.933754,"eighty":13.592458,"marketCap":264504345.06},{"date":"2021-08-20","current":-3.587192,"twenty":-38.166451,"median":-6.925023,"eighty":13.571715,"marketCap":268134226.64},{"date":"2021-08-27","current":-3.738102,"twenty":-38.070329,"median":-6.916541,"eighty":13.55671,"marketCap":282017084.07},{"date":"2021-09-03","current":-4.769728,"twenty":-37.98755,"median":-6.898306,"eighty":13.554209,"marketCap":362669409.39},{"date":"2021-09-10","current":-6.685784,"twenty":-37.864159,"median":-6.894809,"eighty":13.548832,"marketCap":506012767.92},{"date":"2021-09-17","current":-7.160759,"twenty":-37.463083,"median":-6.883012,"eighty":13.530399,"marketCap":650335472.47},{"date":"2021-09-24","current":-6.106889,"twenty":-36.913171,"median":-6.862756,"eighty":13.510716,"marketCap":553259868.85},{"date":"2021-10-01","current":-5.256433,"twenty":-35.156806,"median":-6.832404,"eighty":13.491506,"marketCap":471464168.79},{"date":"2021-10-08","current":-5.389637,"twenty":-33.941418,"median":-6.828226,"eighty":13.468067,"marketCap":482572445.32},{"date":"2021-10-15","current":-5.228008,"twenty":-33.813928,"median":-6.82505,"eighty":13.458079,"marketCap":469240982.6},{"date":"2021-10-22","current":-4.969683,"twenty":-33.674847,"median":-6.818519,"eighty":13.436886,"marketCap":447248312.2},{"date":"2021-10-29","current":-4.93772,"twenty":-33.529972,"median":-6.80948,"eighty":13.4116,"marketCap":441751223.4},{"date":"2021-11-05","current":-4.925457,"twenty":-33.477817,"median":-6.801068,"eighty":13.374153,"marketCap":440348643.4},{"date":"2021-11-12","current":-4.635244,"twenty":-33.379301,"median":-6.786095,"eighty":13.193207,"marketCap":410560017.17},{"date":"2021-11-19","current":-4.477874,"twenty":-33.321351,"median":-6.774618,"eighty":12.681699,"marketCap":392220833.24},{"date":"2021-11-26","current":-4.387949,"twenty":-33.217041,"median":-6.769891,"eighty":12.346895,"marketCap":384170224.06},{"date":"2021-12-03","current":-4.171311,"twenty":-32.886725,"median":-6.750472,"eighty":12.012092,"marketCap":364296344.96},{"date":"2021-12-10","current":-4.34503,"twenty":-32.614359,"median":-6.720553,"eighty":11.599712,"marketCap":380326544.86},{"date":"2021-12-17","current":-4.465612,"twenty":-32.562204,"median":-6.697755,"eighty":5.631996,"marketCap":389559049.5},{"date":"2021-12-23","current":-4.488093,"twenty":-32.504254,"median":-6.676291,"eighty":-3.203807,"marketCap":392937965.37},{"date":"2021-12-31","current":-4.545318,"twenty":-32.457894,"median":-6.670085,"eighty":-3.260118,"marketCap":399939427.95},{"date":"2022-01-07","current":-4.193792,"twenty":-32.289838,"median":-6.664103,"eighty":-3.283334,"marketCap":367962679.75},{"date":"2022-01-14","current":-4.103867,"twenty":-31.982702,"median":-6.644016,"eighty":-3.300129,"marketCap":362663684.75},{"date":"2022-01-21","current":-3.862703,"twenty":-31.959522,"median":-6.631846,"eighty":-3.311983,"marketCap":338951433.59},{"date":"2022-01-28","current":-3.490593,"twenty":-31.814647,"median":-6.626502,"eighty":-3.331742,"marketCap":301444000.45},{"date":"2022-02-04","current":-3.45359,"twenty":-31.669771,"median":-6.611752,"eighty":-3.338964,"marketCap":305756738.76},{"date":"2022-02-11","current":-3.476203,"twenty":-31.600231,"median":-6.601912,"eighty":-3.345041,"marketCap":306740810.9},{"date":"2022-02-18","current":-3.274743,"twenty":-31.29889,"median":-6.580729,"eighty":-3.32779,"marketCap":287130132.59},{"date":"2022-02-25","current":-3.178125,"twenty":-31.29889,"median":-6.561673,"eighty":-3.278849,"marketCap":277026101.85},{"date":"2022-03-04","current":-2.820432,"twenty":-31.29889,"median":-6.539434,"eighty":-3.207006,"marketCap":238172885.83},{"date":"2022-03-11","current":-3.021891,"twenty":-25.386348,"median":-6.4448,"eighty":-3.063416,"marketCap":255967497.26},{"date":"2022-03-18","current":-3.114398,"twenty":-24.66819,"median":-6.388312,"eighty":-3.051904,"marketCap":266546324.12},{"date":"2022-03-25","current":-4.632089,"twenty":-24.12862,"median":-6.33244,"eighty":-3.051904,"marketCap":268779236.35},{"date":"2022-04-01","current":-4.71943,"twenty":-23.24707,"median":-6.28916,"eighty":-3.051904,"marketCap":275086509.93},{"date":"2022-04-08","current":-4.234536,"twenty":-22.893691,"median":-6.265718,"eighty":-3.051904,"marketCap":243225618.88},{"date":"2022-04-14","current":-4.321878,"twenty":-22.574509,"median":-6.242687,"eighty":-3.051904,"marketCap":246659493.14},{"date":"2022-04-22","current":-4.186348,"twenty":-21.958944,"median":-6.223662,"eighty":-3.051904,"marketCap":238306418.02},{"date":"2022-04-29","current":-4.126113,"twenty":-21.787954,"median":-6.193343,"eighty":-3.051904,"marketCap":229629994.73},{"date":"2022-05-06","current":-3.9221,"twenty":-21.704359,"median":-6.162437,"eighty":-3.051904,"marketCap":219432311.69},{"date":"2022-05-13","current":-4.182359,"twenty":-21.563767,"median":-6.13059,"eighty":-3.051904,"marketCap":229901298.01},{"date":"2022-05-20","current":-4.387702,"twenty":-21.51057,"median":-6.091455,"eighty":-3.051904,"marketCap":244445772.76},{"date":"2022-05-27","current":-4.333346,"twenty":-21.33198,"median":-6.055783,"eighty":-3.051904,"marketCap":245167864.8},{"date":"2022-06-03","current":-4.369583,"twenty":-21.225586,"median":-6.031081,"eighty":-3.051904,"marketCap":247324037.51},{"date":"2022-06-10","current":-4.128003,"twenty":-21.088794,"median":-5.975657,"eighty":-3.051904,"marketCap":229396731.56},{"date":"2022-06-17","current":-3.653902,"twenty":-20.997599,"median":-5.921119,"eighty":-3.051904,"marketCap":201903210.21},{"date":"2022-06-24","current":-3.877364,"twenty":-20.777211,"median":-5.877672,"eighty":-3.046971,"marketCap":215991234.18},{"date":"2022-07-01","current":-4.121964,"twenty":-20.565894,"median":-5.820676,"eighty":-3.046971,"marketCap":226416447.89},{"date":"2022-07-08","current":-4.300129,"twenty":-20.487002,"median":-5.788616,"eighty":-3.046971,"marketCap":231130293.13},{"date":"2022-07-15","current":-4.103845,"twenty":-20.352544,"median":-5.770805,"eighty":-3.046971,"marketCap":218688145.31},{"date":"2022-07-22","current":-4.460176,"twenty":-20.203445,"median":-5.724496,"eighty":-3.046971,"marketCap":240786579.43},{"date":"2022-07-29","current":-4.574927,"twenty":-20.072394,"median":-5.688533,"eighty":-3.046971,"marketCap":246427272.54},{"date":"2022-08-05","current":-4.079687,"twenty":-19.967858,"median":-5.640931,"eighty":-3.046971,"marketCap":218813925.45},{"date":"2022-08-12","current":-4.250169,"twenty":-19.691096,"median":-5.609989,"eighty":-3.046971,"marketCap":230131433.41},{"date":"2022-08-19","current":-4.210844,"twenty":-18.18272,"median":-5.588568,"eighty":-3.046971,"marketCap":223263506.02},{"date":"2022-08-26","current":-4.107993,"twenty":-16.068521,"median":-5.56895,"eighty":-3.046971,"marketCap":216830573.71},{"date":"2022-09-02","current":-4.077742,"twenty":-14.220545,"median":-5.552865,"eighty":-3.046971,"marketCap":216032805.98},{"date":"2022-09-09","current":-3.914391,"twenty":-14.069589,"median":-5.536204,"eighty":-3.046971,"marketCap":207545241.97},{"date":"2022-09-16","current":-8.798212,"twenty":-13.708178,"median":-5.521449,"eighty":-3.046971,"marketCap":200926893.16},{"date":"2022-09-23","current":-8.181285,"twenty":-13.065226,"median":-5.521449,"eighty":-3.046971,"marketCap":181261013.13},{"date":"2022-09-30","current":-7.410127,"twenty":-12.683142,"median":-5.521449,"eighty":-3.046971,"marketCap":165576165.91},{"date":"2022-10-07","current":-7.276927,"twenty":-12.501348,"median":-5.521449,"eighty":-3.046971,"marketCap":162107092.58},{"date":"2022-10-14","current":-7.213833,"twenty":-12.413782,"median":-5.521449,"eighty":-3.046971,"marketCap":160200375.21},{"date":"2022-10-21","current":-7.080633,"twenty":-12.205839,"median":-5.521449,"eighty":-3.046971,"marketCap":158244778.34},{"date":"2022-10-28","current":-7.080633,"twenty":-11.858131,"median":-5.521449,"eighty":-3.046971,"marketCap":160431914.09},{"date":"2022-11-04","current":-7.192801,"twenty":-11.676629,"median":-5.521449,"eighty":-3.046971,"marketCap":162472600.12},{"date":"2022-11-11","current":-7.354043,"twenty":-11.530153,"median":-5.521449,"eighty":-3.046971,"marketCap":173080544.31},{"date":"2022-11-18","current":-7.501264,"twenty":-11.179887,"median":-5.521449,"eighty":-3.046971,"marketCap":177130891.19},{"date":"2022-11-25","current":-7.487243,"twenty":-11.049333,"median":-5.521449,"eighty":-3.046971,"marketCap":177406480.19},{"date":"2022-12-02","current":-7.816738,"twenty":-10.761148,"median":-5.521449,"eighty":-3.046971,"marketCap":186767337.74},{"date":"2022-12-09","current":-7.445751,"twenty":-10.674936,"median":-5.521449,"eighty":-3.046971,"marketCap":178803179.47},{"date":"2022-12-16","current":-7.275563,"twenty":-10.5271,"median":-5.521449,"eighty":-3.046971,"marketCap":175790742.23},{"date":"2022-12-23","current":-9.140546,"twenty":-10.428388,"median":-5.521449,"eighty":-3.046971,"marketCap":221227431.76},{"date":"2022-12-30","current":-11.665011,"twenty":-10.428388,"median":-5.521449,"eighty":-3.046971,"marketCap":284076728.65},{"date":"2023-01-06","current":-11.296269,"twenty":-10.428388,"median":-5.521449,"eighty":-3.046971,"marketCap":273198971.56},{"date":"2023-01-13","current":-11.856473,"twenty":-10.428388,"median":-5.521449,"eighty":-3.046971,"marketCap":292300598.29},{"date":"2023-01-20","current":-11.693375,"twenty":-10.428388,"median":-5.521449,"eighty":-3.046971,"marketCap":288748312.74},{"date":"2023-01-27","current":-11.487731,"twenty":-10.428388,"median":-5.521449,"eighty":-3.046971,"marketCap":284162961.35},{"date":"2023-02-03","current":-11.516095,"twenty":-10.428388,"median":-5.521449,"eighty":-3.046971,"marketCap":284771858.93},{"date":"2023-02-10","current":-11.274995,"twenty":-10.428388,"median":-5.521449,"eighty":-3.046971,"marketCap":274373462.2},{"date":"2023-02-17","current":-10.721882,"twenty":-10.428388,"median":-5.521449,"eighty":-3.046971,"marketCap":260524125.61},{"date":"2023-02-24","current":-9.804903,"twenty":-10.351966,"median":-5.521449,"eighty":-3.046971,"marketCap":235729409.16},{"date":"2023-03-03","current":-9.938639,"twenty":-10.240518,"median":-5.521449,"eighty":-3.046971,"marketCap":240059103.24},{"date":"2023-03-10","current":-10.487657,"twenty":-10.269176,"median":-5.521449,"eighty":-3.046971,"marketCap":254887199.23},{"date":"2023-03-17","current":-9.762671,"twenty":-10.351966,"median":-5.521449,"eighty":-3.046971,"marketCap":237141018.02},{"date":"2023-03-24","current":-3.558427,"twenty":-10.351966,"median":-5.510023,"eighty":-3.046971,"marketCap":222413183.09},{"date":"2023-03-31","current":-3.70474,"twenty":-10.350374,"median":-5.475329,"eighty":-3.051904,"marketCap":233872754.24},{"date":"2023-04-06","current":-4.175424,"twenty":-10.350374,"median":-5.461892,"eighty":-3.051904,"marketCap":264939000.76},{"date":"2023-04-14","current":-4.168522,"twenty":-10.351966,"median":-5.426718,"eighty":-3.046971,"marketCap":267687492.26},{"date":"2023-04-21","current":-5.483063,"twenty":-10.351966,"median":-5.426718,"eighty":-3.046971,"marketCap":243240637.27},{"date":"2023-04-28","current":-5.155864,"twenty":-10.351966,"median":-5.400537,"eighty":-3.046971,"marketCap":229834589.44},{"date":"2023-05-05","current":-5.413657,"twenty":-10.351966,"median":-5.374355,"eighty":-3.046971,"marketCap":240928002.86},{"date":"2023-05-12","current":-5.379344,"twenty":-10.351966,"median":-5.374355,"eighty":-3.046971,"marketCap":237571061.37},{"date":"2023-05-19","current":-5.458891,"twenty":-10.351966,"median":-5.369401,"eighty":-3.046971,"marketCap":237735375.26},{"date":"2023-05-26","current":-5.528494,"twenty":-10.353559,"median":-5.358576,"eighty":-3.042037,"marketCap":239811186.19},{"date":"2023-06-02","current":-5.478778,"twenty":-10.353559,"median":-5.358576,"eighty":-3.042037,"marketCap":237909769.16},{"date":"2023-06-09","current":-6.147468,"twenty":-10.353559,"median":-5.358576,"eighty":-3.042037,"marketCap":267896064},{"date":"2023-06-16","current":-6.127573,"twenty":-10.355151,"median":-5.357694,"eighty":-3.037104,"marketCap":270733772.12},{"date":"2023-06-23","current":-5.868942,"twenty":-10.359273,"median":-5.339571,"eighty":-3.026003,"marketCap":260159306.23},{"date":"2023-06-30","current":-5.719731,"twenty":-10.360117,"median":-5.337922,"eighty":-3.023947,"marketCap":251861227},{"date":"2023-07-07","current":-5.483301,"twenty":-10.360117,"median":-5.337922,"eighty":-3.023947,"marketCap":240899542.69},{"date":"2023-07-14","current":-5.73209,"twenty":-10.361709,"median":-5.337922,"eighty":-3.01778,"marketCap":259496725.99},{"date":"2023-07-21","current":-5.771896,"twenty":-10.364704,"median":-5.281009,"eighty":-3.001334,"marketCap":260192082.03},{"date":"2023-07-28","current":-5.572865,"twenty":-10.368178,"median":-5.274846,"eighty":-2.970498,"marketCap":247713519.07},{"date":"2023-08-04","current":-5.383786,"twenty":-10.368178,"median":-5.256433,"eighty":-2.970498,"marketCap":238418063.07},{"date":"2023-08-11","current":-5.493253,"twenty":-10.368178,"median":-5.256433,"eighty":-2.970498,"marketCap":244739600.13},{"date":"2023-08-18","current":-5.264367,"twenty":-10.368178,"median":-5.256433,"eighty":-2.970498,"marketCap":231608108.34},{"date":"2023-08-25","current":-5.204658,"twenty":-10.368178,"median":-5.215448,"eighty":-2.970498,"marketCap":227989160.62},{"date":"2023-09-01","current":-5.791799,"twenty":-10.368178,"median":-5.215448,"eighty":-2.970498,"marketCap":254066503.25},{"date":"2023-09-08","current":-5.811702,"twenty":-10.371653,"median":-5.210444,"eighty":-2.939663,"marketCap":251529477.8},{"date":"2023-09-15","current":-3.537712,"twenty":-10.371653,"median":-5.204658,"eighty":-2.939663,"marketCap":236556926.93},{"date":"2023-09-22","current":-3.364358,"twenty":-10.371653,"median":-5.155864,"eighty":-2.939663,"marketCap":224893242.7},{"date":"2023-09-29","current":-3.280891,"twenty":-10.375127,"median":-5.096373,"eighty":-2.908827,"marketCap":217320910.82},{"date":"2023-10-06","current":-3.094696,"twenty":-10.375127,"median":-5.031733,"eighty":-2.851148,"marketCap":204253835.54},{"date":"2023-10-13","current":-2.790966,"twenty":-10.375127,"median":-4.969683,"eighty":-2.803827,"marketCap":184595973.83},{"date":"2023-10-20","current":-3.009613,"twenty":-10.375127,"median":-4.889725,"eighty":-2.803827,"marketCap":199541631.94},{"date":"2023-10-27","current":-2.977459,"twenty":-10.350374,"median":-4.797022,"eighty":-2.801255,"marketCap":196557438.92},{"date":"2023-11-03","current":-3.054628,"twenty":-10.246887,"median":-4.745606,"eighty":-2.801255,"marketCap":203278715.5},{"date":"2023-11-10","current":-2.861705,"twenty":-10.194286,"median":-4.682251,"eighty":-2.801255,"marketCap":192174114.62},{"date":"2023-11-17","current":-2.958167,"twenty":-10.119517,"median":-4.633667,"eighty":-2.801255,"marketCap":201435523.57},{"date":"2023-11-24","current":-2.958167,"twenty":-10.062201,"median":-4.622203,"eighty":-2.801255,"marketCap":202226328.24},{"date":"2023-12-01","current":-2.900289,"twenty":-9.961163,"median":-4.610907,"eighty":-2.801255,"marketCap":198291350.2},{"date":"2023-12-08","current":-2.98389,"twenty":-9.87529,"median":-4.601221,"eighty":-2.803827,"marketCap":201806104.22},{"date":"2023-12-15","current":-3.061059,"twenty":-9.140546,"median":-4.591347,"eighty":-2.803827,"marketCap":210985908.74},{"date":"2023-12-22","current":-3.183244,"twenty":-8.906537,"median":-4.564194,"eighty":-2.803827,"marketCap":219359377.82},{"date":"2023-12-29","current":-3.369738,"twenty":-8.649589,"median":-4.549405,"eighty":-2.801255,"marketCap":233985495.13},{"date":"2024-01-05","current":-3.466199,"twenty":-8.206523,"median":-4.541709,"eighty":-2.798683,"marketCap":238125054.25},{"date":"2024-01-12","current":-3.288461,"twenty":-8.043571,"median":-4.510575,"eighty":-2.798683,"marketCap":225691995.84},{"date":"2024-01-19","current":-3.159502,"twenty":-7.828871,"median":-4.493763,"eighty":-2.79611,"marketCap":215192166.45},{"date":"2024-01-26","current":-3.243326,"twenty":-7.762678,"median":-4.465612,"eighty":-2.798683,"marketCap":220350708.79},{"date":"2024-02-02","current":-3.030543,"twenty":-7.670049,"median":-4.445174,"eighty":-2.798683,"marketCap":206095325.45},{"date":"2024-02-09","current":-2.888688,"twenty":-7.556932,"median":-4.401421,"eighty":-2.798683,"marketCap":194925783.64},{"date":"2024-02-16","current":-2.972511,"twenty":-7.499633,"median":-4.379774,"eighty":-2.798683,"marketCap":200474214.09},{"date":"2024-02-23","current":-3.095023,"twenty":-7.470418,"median":-4.363544,"eighty":-2.798683,"marketCap":209865625.74},{"date":"2024-03-01","current":-2.933823,"twenty":-7.420141,"median":-4.344944,"eighty":-2.801255,"marketCap":198806098.8},{"date":"2024-03-08","current":-2.953167,"twenty":-7.397508,"median":-4.334856,"eighty":-2.801255,"marketCap":202325849.18},{"date":"2024-03-15","current":-2.779072,"twenty":-7.361054,"median":-4.322214,"eighty":-2.788587,"marketCap":189755455.83},{"date":"2024-03-22","current":-23.120595,"twenty":-7.342826,"median":-4.320063,"eighty":-2.802745,"marketCap":190056362.25},{"date":"2024-03-28","current":-23.33418,"twenty":-7.361054,"median":-4.328677,"eighty":-2.81776,"marketCap":190796870.81},{"date":"2024-04-05","current":-23.547765,"twenty":-7.409744,"median":-4.33992,"eighty":-2.845714,"marketCap":193630874.43},{"date":"2024-04-12","current":-24.936069,"twenty":-7.436996,"median":-4.348445,"eighty":-2.859877,"marketCap":202169905.75},{"date":"2024-04-19","current":-22.533236,"twenty":-7.492398,"median":-4.37773,"eighty":-2.888184,"marketCap":181890162.08},{"date":"2024-04-26","current":-23.974936,"twenty":-7.5294,"median":-4.393289,"eighty":-2.900289,"marketCap":194419135.51},{"date":"2024-05-03","current":-23.547765,"twenty":-7.650557,"median":-4.431399,"eighty":-2.912127,"marketCap":190709942.23},{"date":"2024-05-10","current":-24.135124,"twenty":-7.749437,"median":-4.461686,"eighty":-2.924996,"marketCap":196856903.35},{"date":"2024-05-17","current":-25.737013,"twenty":-7.820782,"median":-4.486213,"eighty":-2.937864,"marketCap":211770859.78},{"date":"2024-05-24","current":-28.51362,"twenty":-8.036446,"median":-4.508531,"eighty":-2.953167,"marketCap":233627131.72},{"date":"2024-05-31","current":-27.018524,"twenty":-8.162307,"median":-4.539348,"eighty":-2.958167,"marketCap":221785110.61},{"date":"2024-06-07","current":-27.071921,"twenty":-8.649589,"median":-4.549405,"eighty":-2.976469,"marketCap":222997213.28},{"date":"2024-06-14","current":-22.693425,"twenty":-8.945433,"median":-4.570794,"eighty":-2.997845,"marketCap":184918432.72},{"date":"2024-06-21","current":-21.945876,"twenty":-9.389396,"median":-4.592936,"eighty":-3.016044,"marketCap":178022165.67},{"date":"2024-06-28","current":-20.039381,"twenty":-9.816165,"median":-4.598456,"eighty":-3.029253,"marketCap":162400290.12},{"date":"2024-07-05","current":-21.386746,"twenty":-9.933008,"median":-4.608626,"eighty":-3.034703,"marketCap":175024501.62},{"date":"2024-07-12","current":-22.028348,"twenty":-10.123506,"median":-4.6185,"eighty":-3.056838,"marketCap":181274696.16},{"date":"2024-07-15","current":-22.188748,"twenty":-10.223117,"median":-4.620968,"eighty":-3.060215,"marketCap":183332051.95},{"date":"2024-08-02","current":-21.70807,"twenty":-10.377853,"median":-4.663713,"eighty":-3.112884,"marketCap":177232621.87},{"date":"2024-08-09","current":-21.173388,"twenty":-10.703192,"median":-4.725454,"eighty":-3.159502,"marketCap":174866406.28},{"date":"2024-08-16","current":-21.97541,"twenty":-10.869733,"median":-4.773191,"eighty":-3.177076,"marketCap":182726117.09},{"date":"2024-08-23","current":-22.296219,"twenty":-11.245212,"median":-4.860085,"eighty":-3.19112,"marketCap":187473486.62},{"date":"2024-08-30","current":-22.349687,"twenty":-11.307615,"median":-4.953819,"eighty":-3.21544,"marketCap":187402673.9},{"date":"2024-09-06","current":-22.56356,"twenty":-11.419655,"median":-5.021235,"eighty":-3.23056,"marketCap":189363802.66},{"date":"2024-09-13","current":-4.944721,"twenty":-11.499077,"median":-5.076491,"eighty":-3.250656,"marketCap":185806252.48},{"date":"2024-09-20","current":-4.687976,"twenty":-11.499077,"median":-5.076491,"eighty":-3.268131,"marketCap":177806796.61},{"date":"2024-09-27","current":-4.778312,"twenty":-11.499077,"median":-5.076491,"eighty":-3.280891,"marketCap":181861038.34},{"date":"2024-10-04","current":-4.649939,"twenty":-11.499077,"median":-5.076491,"eighty":-3.298003,"marketCap":174402168.74},{"date":"2024-10-11","current":-4.564357,"twenty":-11.499077,"median":-5.076491,"eighty":-3.333186,"marketCap":169808260.68},{"date":"2024-10-18","current":-4.445494,"twenty":-11.499077,"median":-5.076491,"eighty":-3.359403,"marketCap":163917663.24},{"date":"2024-10-25","current":-4.041358,"twenty":-11.499077,"median":-5.076491,"eighty":-3.374422,"marketCap":148645851.16},{"date":"2024-10-31","current":-4.112676,"twenty":-11.499077,"median":-5.076491,"eighty":-3.405067,"marketCap":152057385.45},{"date":"2024-11-08","current":-3.827404,"twenty":-11.501913,"median":-5.078739,"eighty":-3.415715,"marketCap":140578965.59},{"date":"2024-11-15","current":-3.423268,"twenty":-11.501913,"median":-5.078739,"eighty":-3.435473,"marketCap":123327471.43},{"date":"2024-11-22","current":-3.641977,"twenty":-11.501913,"median":-5.078739,"eighty":-3.466199,"marketCap":130091889.23},{"date":"2024-11-29","current":-3.385232,"twenty":-11.501913,"median":-5.078739,"eighty":-3.466199,"marketCap":121609782.68},{"date":"2024-12-06","current":-3.523113,"twenty":-11.501913,"median":-5.078739,"eighty":-3.467385,"marketCap":126803781.84},{"date":"2024-12-13","current":-4.516812,"twenty":-11.501913,"median":-5.078739,"eighty":-3.492278,"marketCap":161324192.36},{"date":"2024-12-20","current":-4.573867,"twenty":-11.501913,"median":-5.087357,"eighty":-3.507039,"marketCap":161699858.8},{"date":"2024-12-27","current":-4.635676,"twenty":-11.501913,"median":-5.087357,"eighty":-3.515261,"marketCap":164397025.62},{"date":"2025-01-03","current":-4.545339,"twenty":-11.501913,"median":-5.087357,"eighty":-3.530292,"marketCap":158730278.95},{"date":"2025-01-10","current":-4.298103,"twenty":-11.504749,"median":-5.091865,"eighty":-3.541924,"marketCap":150668121.27},{"date":"2025-01-17","current":-4.26295,"twenty":-11.504749,"median":-5.091865,"eighty":-3.559669,"marketCap":149435834.88},{"date":"2025-01-24","current":-4.203879,"twenty":-11.504749,"median":-5.091865,"eighty":-3.578923,"marketCap":149037466.94},{"date":"2025-01-31","current":-4.430317,"twenty":-11.504749,"median":-5.091865,"eighty":-3.606902,"marketCap":157261721.05},{"date":"2025-02-07","current":-4.819201,"twenty":-11.504749,"median":-5.091865,"eighty":-3.631557,"marketCap":170267096.91},{"date":"2025-02-14","current":-4.735517,"twenty":-11.504749,"median":-5.091865,"eighty":-3.641851,"marketCap":168411308.62},{"date":"2025-02-21","current":-5.414832,"twenty":-11.504749,"median":-5.12664,"eighty":-3.661715,"marketCap":192952986.61},{"date":"2025-02-28","current":-5.230236,"twenty":-11.504749,"median":-5.180286,"eighty":-3.69224,"marketCap":185327775.23},{"date":"2025-03-07","current":-4.996414,"twenty":-11.507586,"median":-5.184755,"eighty":-3.746078,"marketCap":184251542.13},{"date":"2025-03-14","current":-4.60753,"twenty":-11.42391,"median":-5.155864,"eighty":-3.756314,"marketCap":170446079.3},{"date":"2025-03-21","current":-4.637066,"twenty":-11.301942,"median":-5.096373,"eighty":-3.756314,"marketCap":171333937.72},{"date":"2025-03-28","current":-3.154525,"twenty":-11.242375,"median":-5.056713,"eighty":-3.746078,"marketCap":168455848.45},{"date":"2025-04-04","current":-2.920731,"twenty":-10.859628,"median":-4.996414,"eighty":-3.695039,"marketCap":159941858.53},{"date":"2025-04-11","current":-2.886848,"twenty":-10.721882,"median":-4.945955,"eighty":-3.665325,"marketCap":159730723.63},{"date":"2025-04-17","current":-2.961391,"twenty":-10.420086,"median":-4.931589,"eighty":-3.645809,"marketCap":166594221.06},{"date":"2025-04-25","current":-2.978332,"twenty":-10.145916,"median":-4.873349,"eighty":-3.632766,"marketCap":167299960.26}],"updateTime":1745845840826}}}